{"component": "definition", "props": {"groups": [{"snippet": "has the meaning set forth in Section 7.4.3.", "samples": [{"hash": "toyNMkJhal", "uri": "/contracts/toyNMkJhal#generic-competition", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 34.1444206238, "published": true}, {"hash": "8wkFXVcAmCH", "uri": "/contracts/8wkFXVcAmCH#generic-competition", "label": "Development and Marketing Agreement", "score": 27.0520191193, "published": true}, {"hash": "h4IzP3EHexR", "uri": "/contracts/h4IzP3EHexR#generic-competition", "label": "License and Collaboration Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 24.5646820068, "published": true}], "snippet_links": [{"key": "section-743", "type": "clause", "offset": [29, 42]}], "size": 32, "hash": "d0bce0bb76dd68ca9ce2a5bdcd726688", "id": 1}, {"snippet": "means, with respect to a Product in any country in a given calendar quarter, that, during such calendar quarter, (i) one or more Generic Products are commercially available in such country, and (ii) aggregate Net Sales of such Product in such country in such calendar quarter equal less than [****] percent ([****]%) of the average aggregate Net Sales of the Product over the four (4) calendar quarters immediately prior to the calendar quarter in which one or more Generic Products first became commercially available in such country.", "samples": [{"hash": "hOc38o1xSrk", "uri": "/contracts/hOc38o1xSrk#generic-competition", "label": "Asset Purchase Agreement (Macrogenics Inc)", "score": 34.1991767883, "published": true}, {"hash": "2BlVTipMYym", "uri": "/contracts/2BlVTipMYym#generic-competition", "label": "Asset Purchase Agreement (Provention Bio, Inc.)", "score": 29.4654350281, "published": true}, {"hash": "bqnSgdDMovV", "uri": "/contracts/bqnSgdDMovV#generic-competition", "label": "Asset Purchase Agreement (Provention Bio, Inc.)", "score": 29.4435310364, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "generic-products", "type": "clause", "offset": [129, 145]}, {"key": "commercially-available", "type": "definition", "offset": [150, 172]}, {"key": "aggregate-net-sales", "type": "definition", "offset": [199, 218]}, {"key": "the-product", "type": "clause", "offset": [355, 366]}, {"key": "calendar-quarters", "type": "clause", "offset": [385, 402]}, {"key": "prior-to-the", "type": "clause", "offset": [415, 427]}], "size": 30, "hash": "3c95d9a6a80f2ff16d040e46d49cc731", "id": 2}, {"snippet": "means, with respect to a Licensed Product in a given country in a given Calendar Year, that, during such Calendar Year one or more Generic Products shall be commercially available in such country.", "samples": [{"hash": "7TYfZT5QQf1", "uri": "/contracts/7TYfZT5QQf1#generic-competition", "label": "Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.)", "score": 32.4798088074, "published": true}, {"hash": "kx2QDOgD4UT", "uri": "/contracts/kx2QDOgD4UT#generic-competition", "label": "Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.)", "score": 32.3073234558, "published": true}, {"hash": "9GLdmDC2Q3U", "uri": "/contracts/9GLdmDC2Q3U#generic-competition", "label": "Master Research and Collaboration Agreement (Agios Pharmaceuticals Inc)", "score": 27.6009578705, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "licensed-product", "type": "definition", "offset": [25, 41]}, {"key": "calendar-year", "type": "clause", "offset": [72, 85]}, {"key": "year-one", "type": "clause", "offset": [114, 122]}, {"key": "generic-products", "type": "clause", "offset": [131, 147]}, {"key": "commercially-available", "type": "definition", "offset": [157, 179]}], "size": 22, "hash": "60139a6a6d516fbf10617fbf1a99d671", "id": 3}, {"snippet": "means with respect to a Licensed Product in any particular country in the Territory, the existence on the market of any Generic Product in competition with such Licensed Product in such country.", "samples": [{"hash": "9PnLzp6dzA6", "uri": "/contracts/9PnLzp6dzA6#generic-competition", "label": "Licence Agreement", "score": 31.3408622742, "published": true}, {"hash": "bdNfl2NO65U", "uri": "/contracts/bdNfl2NO65U#generic-competition", "label": "Licence Agreement (ProNAi Therapeutics Inc)", "score": 25.8583164215, "published": true}, {"hash": "AiZjOaRZPd", "uri": "https://s28.q4cdn.com/726829854/files/doc_financials/2016/q3/SRRA-(Sierra-Oncology-Inc.)-(10-Q)-2016-11-10.pdf", "label": "s28.q4cdn.com", "score": 10.0198497772, "published": false}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [6, 21]}, {"key": "licensed-product", "type": "definition", "offset": [24, 40]}, {"key": "in-the-territory", "type": "clause", "offset": [67, 83]}, {"key": "the-market", "type": "clause", "offset": [102, 112]}, {"key": "generic-product", "type": "clause", "offset": [120, 135]}], "size": 16, "hash": "0667f9dd7a10be6b27394cd24266fad8", "id": 4}, {"snippet": "shall have the meaning assigned thereto in Section 9.6.5(a).", "samples": [{"hash": "cNKwOWCz74F", "uri": "/contracts/cNKwOWCz74F#generic-competition", "label": "Research Collaboration and License Agreement (Vitae Pharmaceuticals, Inc)", "score": 25.7227916718, "published": true}, {"hash": "eCIOWK5GFkW", "uri": "/contracts/eCIOWK5GFkW#generic-competition", "label": "Research Collaboration and License Agreement (Vitae Pharmaceuticals, Inc)", "score": 25.6926765442, "published": true}, {"hash": "hWicZoQNPs", "uri": "/contracts/hWicZoQNPs#generic-competition", "label": "Research Collaboration and License Agreement (Vitae Pharmaceuticals, Inc)", "score": 25.6570835114, "published": true}], "snippet_links": [], "size": 14, "hash": "cf76fea85b31bd798487546cae0cc782", "id": 5}, {"snippet": "means, with respect to a Product in any country in the Territory, one (1) or more Third Parties have received Regulatory Approval to sell a Generic Product to such Product in such country and such Generic Product(s) is commercially available in such country.", "samples": [{"hash": "2ez19I7ilry", "uri": "/contracts/2ez19I7ilry#generic-competition", "label": "Exclusive License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 30.4072551727, "published": true}, {"hash": "fIgWtHiCQWi", "uri": "/contracts/fIgWtHiCQWi#generic-competition", "label": "Exclusive License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 30.3305950165, "published": true}, {"hash": "10sshq3DEr7", "uri": "/contracts/10sshq3DEr7#generic-competition", "label": "Exclusive License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 26.7878170013, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "in-the-territory", "type": "clause", "offset": [48, 64]}, {"key": "third-parties", "type": "definition", "offset": [82, 95]}, {"key": "regulatory-approval", "type": "definition", "offset": [110, 129]}, {"key": "to-sell", "type": "clause", "offset": [130, 137]}, {"key": "generic-product", "type": "clause", "offset": [140, 155]}, {"key": "commercially-available", "type": "definition", "offset": [219, 241]}], "size": 13, "hash": "90f7cb055978a530666eba9025045979", "id": 6}, {"snippet": "is defined in Section 5.5.2(a).", "samples": [{"hash": "jpnZcbP2zYu", "uri": "/contracts/jpnZcbP2zYu#generic-competition", "label": "Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.)", "score": 31.8446273804, "published": true}, {"hash": "ggnshgntmlA", "uri": "/contracts/ggnshgntmlA#generic-competition", "label": "Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.)", "score": 26.7494869232, "published": true}, {"hash": "lgwM84kDb46", "uri": "/contracts/lgwM84kDb46#generic-competition", "label": "Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.)", "score": 26.7385349274, "published": true}], "snippet_links": [{"key": "defined-in-section", "type": "clause", "offset": [3, 21]}], "size": 13, "hash": "f07497cbfc68cce303d26ff61c7a39c1", "id": 7}, {"snippet": "means, with respect to a particular Product in a particular country, when (a) one or more Generic Product(s) are being marketed in such country; and (b) there are no Valid Claims covering such Product provided, however, that for defining a Generic Product in the United States the criteria will be either having no Valid Patent Claim covering the United States or having Paragraph IV certification or regulatory exclusivity in respect of such Product, in such country.", "samples": [{"hash": "6B9XRRxpsDr", "uri": "/contracts/6B9XRRxpsDr#generic-competition", "label": "Research and License Agreement (INNOCAN PHARMA Corp)", "score": 36.5564689636, "published": true}, {"hash": "gtLIumvUpTe", "uri": "/contracts/gtLIumvUpTe#generic-competition", "label": "Research and License Agreement (Therapix Biosciences Ltd.)", "score": 29.3661880493, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "particular-product", "type": "definition", "offset": [25, 43]}, {"key": "generic-product", "type": "clause", "offset": [90, 105]}, {"key": "valid-claims", "type": "definition", "offset": [166, 178]}, {"key": "product-provided", "type": "clause", "offset": [193, 209]}, {"key": "in-the-united-states", "type": "clause", "offset": [256, 276]}, {"key": "the-criteria", "type": "clause", "offset": [277, 289]}, {"key": "valid-patent-claim", "type": "definition", "offset": [315, 333]}, {"key": "paragraph-iv-certification", "type": "definition", "offset": [371, 397]}, {"key": "regulatory-exclusivity", "type": "definition", "offset": [401, 423]}, {"key": "in-respect-of", "type": "definition", "offset": [424, 437]}], "size": 10, "hash": "55c96bfb7bda94007820dcb9c513b0d4", "id": 8}, {"snippet": "means, with respect to a Licensed Product in the United States, United Kingdom, Germany, France, Spain or Italy, when Net Sales of such Licensed Product in such country decrease by [**] percent ([**]%) or more from the Net Sales of such Licensed Product in such country measured as of each of the four (4) Calendar Quarters immediately preceding the Calendar Quarter during which the entry of a Generic Product occurs in such country.", "samples": [{"hash": "cuT7ZTycZx8", "uri": "/contracts/cuT7ZTycZx8#generic-competition", "label": "Development and Licensing Agreement", "score": 27.0383300781, "published": true}, {"hash": "fX8f64JF8bm", "uri": "/contracts/fX8f64JF8bm#generic-competition", "label": "Research and License Agreement (Aveo Pharmaceuticals Inc)", "score": 22.9082813263, "published": true}, {"hash": "idDweDVKcRk", "uri": "/contracts/idDweDVKcRk#generic-competition", "label": "Research and License Agreement (Aveo Pharmaceuticals Inc)", "score": 22.6016426086, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "licensed-product", "type": "definition", "offset": [25, 41]}, {"key": "in-the-united-states", "type": "clause", "offset": [42, 62]}, {"key": "united-kingdom", "type": "definition", "offset": [64, 78]}, {"key": "net-sales", "type": "clause", "offset": [118, 127]}, {"key": "the-net", "type": "clause", "offset": [215, 222]}, {"key": "calendar-quarters", "type": "clause", "offset": [306, 323]}, {"key": "generic-product", "type": "clause", "offset": [395, 410]}], "size": 7, "hash": "2ba58981cb8d2889d26cdd67454d5e1c", "id": 9}, {"snippet": "means [***].", "samples": [{"hash": "gGAVsbBhtLp", "uri": "/contracts/gGAVsbBhtLp#generic-competition", "label": "License Agreement (Zai Lab LTD)", "score": 32.1622161865, "published": true}, {"hash": "jeOfaT5XwFK", "uri": "/contracts/jeOfaT5XwFK#generic-competition", "label": "License Agreement (Cullinan Oncology, LLC)", "score": 31.9897327423, "published": true}], "snippet_links": [], "size": 7, "hash": "42145ccc68badf480a8ed917c57dd5fc", "id": 10}], "next_curs": "CmASWmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIcZ2VuZXJpYy1jb21wZXRpdGlvbiMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "has the meaning set forth in Section 7.4.3.", "size": 507, "title": "Generic Competition", "id": "generic-competition", "examples": ["For purposes of illustration only, if Y\u2587\u2587\u2587\u2587\u2587 would be entitled to receive the royalty amount of $100 if not for any royalty reduction, as aforementioned, then in the event that there is <strong>Generic Competition</strong>, then Yissum will be entitled to receive the royalty amount of $50.", "In the event that during the Term of the License (as defined in Section 4 above), there is any Competition (as defined below) with respect to a particular Product in a particular country in which such Product is being sold, and for so long as such <strong>Generic Competition</strong> persists, the royalty amount payable to Yissum for sales of such Product (only) in such country shall be reduced by 50% (fifty percent)."], "related": [["competitive-product", "Competitive Product", "Competitive Product"], ["competing-product", "Competing Product", "Competing Product"], ["competitive-infringement", "Competitive Infringement", "Competitive Infringement"], ["generic-product", "Generic Product", "Generic Product"], ["anti-competitive-practice", "Anti-competitive practice", "Anti-competitive practice"]], "related_snippets": [], "updated": "2026-03-18T05:31:41+00:00"}, "json": true, "cursor": ""}}